Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Trojano

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosisF Patti, M P Amato, S Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosisB Goretti, E Portaccio, A Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2009
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) studyF Patti, M P Amato, M Trojano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosisU Nocentini, P Pasqualetti, S Bonavita, et al.
Neurology|May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MSM P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosisF Patti, M P Amato, S Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosisB Goretti, E Portaccio, A Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2009
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) studyF Patti, M P Amato, M Trojano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosisU Nocentini, P Pasqualetti, S Bonavita, et al.
Neurology|May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MSM P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Pageof 11